129 related articles for article (PubMed ID: 10934580)
1. Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
Martin L; Bäurle A; Fiehn W; Volkmann M
Clin Lab; 2000; 46(7-8):339-44. PubMed ID: 10934580
[TBL] [Abstract][Full Text] [Related]
2. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
Volkmann M; Martin L; Bäurle A; Heid H; Strassburg CP; Trautwein C; Fiehn W; Manns MP
Hepatology; 2001 Mar; 33(3):591-6. PubMed ID: 11230739
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies and autoantigens in autoimmune hepatitis.
Strassburg CP; Manns MP
Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
[TBL] [Abstract][Full Text] [Related]
6. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
[TBL] [Abstract][Full Text] [Related]
7. SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
Volkmann M; Luithle D; Zentgraf H; Schnölzer M; Fiedler S; Heid H; Schulze-Bergkamen A; Strassburg CP; Gehrke SG; Manns MP
J Autoimmun; 2010 Feb; 34(1):59-65. PubMed ID: 19683415
[TBL] [Abstract][Full Text] [Related]
8. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
10. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients].
Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642
[TBL] [Abstract][Full Text] [Related]
13. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW
Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173
[TBL] [Abstract][Full Text] [Related]
14. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis.
Stechemesser E; Klein R; Berg PA
Hepatology; 1993 Jul; 18(1):1-9. PubMed ID: 8325600
[TBL] [Abstract][Full Text] [Related]
15. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
[TBL] [Abstract][Full Text] [Related]
16. Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs.
Torres-Collado AX; Czaja AJ; Gelpí C
Liver Int; 2005 Apr; 25(2):410-9. PubMed ID: 15780067
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P
Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051
[TBL] [Abstract][Full Text] [Related]
19. Anti-SLA seropositive autoimmune hepatitis sera recognize distinct subunits of glutathione S-transferase: high prevalence of the Ya autoantigen.
Wesierska-Gadek J; Lindner H; Hitchman E; Sarg B; Penner E
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):301-7. PubMed ID: 12030435
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical relevance of anti-soluble liver antigen (SLA) antibodies in autoimmune hepatitis.
Ballot E; Bruneel A; Johanet C; Yamamoto AM
Hepatology; 2002 Sep; 36(3):765-6; author reply 766-7. PubMed ID: 12198675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
